First Citizens Bank & Trust Co. lowered its stake in shares of Intuitive Surgical Inc. (NASDAQ:ISRG) by 7.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,808 shares of the company’s stock after selling 210 shares during the period. First Citizens Bank & Trust Co.’s holdings in Intuitive Surgical were worth $1,857,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently added to or reduced their stakes in ISRG. Acrospire Investment Management LLC acquired a new stake in Intuitive Surgical during the first quarter worth $120,000. Bartlett & Co. LLC raised its stake in Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock worth $146,000 after buying an additional 15 shares during the last quarter. IFP Advisors Inc raised its stake in Intuitive Surgical by 3.3% in the first quarter. IFP Advisors Inc now owns 284 shares of the company’s stock worth $171,000 after buying an additional 9 shares during the last quarter. Bessemer Group Inc. raised its stake in Intuitive Surgical by 59.0% in the first quarter. Bessemer Group Inc. now owns 318 shares of the company’s stock worth $191,000 after buying an additional 118 shares during the last quarter. Finally, Checchi Capital Advisers LLC raised its stake in Intuitive Surgical by 4.5% in the second quarter. Checchi Capital Advisers LLC now owns 392 shares of the company’s stock worth $259,000 after buying an additional 17 shares during the last quarter. Institutional investors own 91.90% of the company’s stock.
Shares of Intuitive Surgical Inc. (NASDAQ:ISRG) traded down 2.13% during midday trading on Tuesday, reaching $709.21. The company’s stock had a trading volume of 130,506 shares. The stock’s 50-day moving average price is $698.87 and its 200-day moving average price is $661.85. Intuitive Surgical Inc. has a 12-month low of $447.00 and a 12-month high of $727.25. The company has a market cap of $27.30 billion, a P/E ratio of 40.25 and a beta of 0.72.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 19th. The company reported $5.62 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $4.97 by $0.65. The firm had revenue of $670 million for the quarter, compared to the consensus estimate of $640.69 million. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. During the same quarter in the previous year, the business earned $4.57 EPS. On average, analysts expect that Intuitive Surgical Inc. will post $21.30 EPS for the current fiscal year.
ISRG has been the topic of a number of recent analyst reports. Stifel Nicolaus increased their target price on Intuitive Surgical from $700.00 to $800.00 and gave the stock a “buy” rating in a research note on Wednesday, July 20th. Canaccord Genuity increased their target price on Intuitive Surgical from $700.00 to $750.00 and gave the stock a “buy” rating in a research note on Wednesday, July 20th. Bank of America Corp. restated a “buy” rating on shares of Intuitive Surgical in a research note on Wednesday, June 22nd. Barclays PLC restated a “buy” rating on shares of Intuitive Surgical in a research note on Saturday, June 18th. Finally, Evercore ISI restated a “buy” rating and set a $775.00 price target (up previously from $750.00) on shares of Intuitive Surgical in a research note on Wednesday, July 20th. One research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $701.42.
In related news, CEO Gary S. Guthart sold 13,400 shares of the business’s stock in a transaction on Monday, August 1st. The stock was sold at an average price of $698.00, for a total value of $9,353,200.00. Following the sale, the chief executive officer now owns 78,780 shares in the company, valued at approximately $54,988,440. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Alan J. Levy sold 3,188 shares of the business’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $694.11, for a total value of $2,212,822.68. Following the completion of the sale, the director now owns 5,401 shares in the company, valued at approximately $3,748,888.11. The disclosure for this sale can be found here. 3.10% of the stock is owned by corporate insiders.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.